327 related articles for article (PubMed ID: 17714491)
1. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
[TBL] [Abstract][Full Text] [Related]
2. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections.
Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474
[TBL] [Abstract][Full Text] [Related]
3. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
Li X; Johnson DE; Mobley HL
Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487
[TBL] [Abstract][Full Text] [Related]
4. Characterization of adhesin variants in Indian isolates of enteroaggregative Escherichia coli.
Bhardwaj R; Majumdar S; Ganguly NK; Taneja N; Dutta S; Ramamurthy T; Chakraborti A
FEMS Microbiol Lett; 2006 May; 258(2):274-83. PubMed ID: 16640585
[TBL] [Abstract][Full Text] [Related]
5. Fimbriae of uropathogenic Proteus mirabilis.
Rocha SP; Pelayo JS; Elias WP
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
[TBL] [Abstract][Full Text] [Related]
6. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
[TBL] [Abstract][Full Text] [Related]
7. Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence.
Schembri MA; Klemm P
Infect Immun; 2001 Mar; 69(3):1322-8. PubMed ID: 11179294
[TBL] [Abstract][Full Text] [Related]
8. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation.
Jansen AM; Lockatell V; Johnson DE; Mobley HL
Infect Immun; 2004 Dec; 72(12):7294-305. PubMed ID: 15557655
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
[TBL] [Abstract][Full Text] [Related]
10. The majority of enteroaggregative Escherichia coli strains produce the E. coli common pilus when adhering to cultured epithelial cells.
Avelino F; Saldaña Z; Islam S; Monteiro-Neto V; Dall'Agnol M; Eslava CA; Girón JA
Int J Med Microbiol; 2010 Nov; 300(7):440-8. PubMed ID: 20452276
[TBL] [Abstract][Full Text] [Related]
11. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
[TBL] [Abstract][Full Text] [Related]
12. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
Mobley HL; Island MD; Massad G
Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
[TBL] [Abstract][Full Text] [Related]
13. Mucosal vaccination of mice with recombinant Proteus mirabilis structural fimbrial proteins.
Scavone P; Sosa V; Pellegrino R; Galvalisi U; Zunino P
Microbes Infect; 2004 Jul; 6(9):853-60. PubMed ID: 15374007
[TBL] [Abstract][Full Text] [Related]
14. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide sequences of two fimbrial major subunit genes, pmpA and ucaA, from canine-uropathogenic Proteus mirabilis strains.
Bijlsma IGW; Dijk LV; Kusters JG; Gaastra W
Microbiology (Reading); 1995 Jun; 141 ( Pt 6)():1349-1357. PubMed ID: 7670636
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections.
Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P
FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373
[TBL] [Abstract][Full Text] [Related]
17. MrpH, a new class of metal-binding adhesin, requires zinc to mediate biofilm formation.
Jiang W; Ubhayasekera W; Breed MC; Norsworthy AN; Serr N; Mobley HLT; Pearson MM; Knight SD
PLoS Pathog; 2020 Aug; 16(8):e1008707. PubMed ID: 32780778
[TBL] [Abstract][Full Text] [Related]
18. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.
Spurbeck RR; Stapleton AE; Johnson JR; Walk ST; Hooton TM; Mobley HL
Infect Immun; 2011 Dec; 79(12):4753-63. PubMed ID: 21911462
[TBL] [Abstract][Full Text] [Related]
19. Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates.
Nucleo E; Fugazza G; Migliavacca R; Spalla M; Comelli M; Pagani L; Debiaggi M
New Microbiol; 2010 Jan; 33(1):37-45. PubMed ID: 20402412
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model.
Habibi M; Asadi Karam MR; Bouzari S
Int Immunopharmacol; 2015 Sep; 28(1):70-8. PubMed ID: 26033493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
